Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses

Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses

US Patent 12227548 · Granted Feb 18, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating anemia in myelodysplastic syndromes2025
Small molecule IRE1-α inhibitors2021
Modulation of breast cancer growth by modulation of XBP1 activity2020
Compounds for inducing anti-tumor immunity and methods thereof2019
Compounds for inducing anti-tumor immunity and methods thereof2019
Small molecule IRE1-α inhibitors2018
Methods for increasing immune responses using agents that directly bind to and a2018
Compounds for inducing anti-tumor immunity and methods thereof2018
Methods for modulating skeletal remodeling and patterning by modulating SHN2 act2017
Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity2015
Fused bicyclic mTOR inhibitors2014
Method for reducing gastro-intestinal inflammation using Bifidobacterium animali2014